Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas

Nathan, Cherie-Ann; Carter, Peggy; Liu, Li; Li, Benjamin DL; Abreo, Fleurette; Tudor, Ann; Zimmer, Stephen G; De Benedetti, Arrigo
August 1997
Oncogene;8/28/97, Vol. 15 Issue 9, p1087
Academic Journal
The translation initiation factor eIF4E is a novel proto-oncogene found over expressed in most breast carcinomas (Kerekatte et al., 1995), but the pathology where this elevation is initially manifested and its possible role in cancer progression are unknown. We report that eIF4E is markedly increased in vascularized malignant ductules of invasive carcinomas, whereas necrotic and avascular ductal carcinomas in situ display significantly lower levels. eIF4E facilitates the synthesis of FGF-2, a powerful tumor angiogenic factor. Conversely, reducing eIF4E with antisense RNA in MDA-435 cells suppresses their tumorigenic and angiogenic properties, consistent with loss of FGF-2 synthesis. These findings suggest a causal role for eIF4E in tumor vascularization.


Related Articles

  • Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Melchor, L.; Honrado, E.; García, M. J.; Álvarez, S.; Palacios, J.; Osorio, A.; Nathanson, K. L.; Benítez, J. // Oncogene;5/15/2008, Vol. 27 Issue 22, p3165 

    Five breast cancer subtypes have been described in sporadic breast cancer (SBC) using expression arrays: basal-like, ERBB2, normal breast-like, luminal A and B. These molecular subtypes show different genomic aberration patterns (GAPs). Recently, our group described these breast cancer subtypes...

  • Evaluation of Dual Immunohistochemistry and Chromogenic In Situ Hybridization for HER2 on a Single Section. Reisenbichler, Emily S.; Horton, Debra; Rasco, Marva; Andea, Aleodor; Hameed, Omar // American Journal of Clinical Pathology;Jan2012, Vol. 137 Issue 1, p102 

    The evaluation of HER2 status in invasive breast carcinoma can be performed by multiple methods. We assessed the feasibility of performing 2 of these, chromogenic in situ hybridization (CISH) and immunohistochemical staining, on single tissue sections of breast carcinoma. During assay...

  • Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses. Joensuu, Kristiina; Hagström, Jaana; Leidenius, Marjut; Haglund, Caj; Andersson, Leif; Sariola, Hannu; Heikkilä, Päivi; Hagström, Jaana; Andersson, Leif C; Heikkilä, Päivi // Virchows Archiv;Jul2011, Vol. 459 Issue 1, p31 

    Breast cancer is known for its propensity to recur decades after treatment. The biology behind the phenomenon of tumor dormancy is still poorly understood. Bmi-1, c-myc, and Snail are transcription factors that have prognostic roles in several malignancies. In order to reveal whether any of...

  • Increased c-kit (CD117) expression in malignant mammary phyllodes tumors. Tse, Gary M.K.; Putti, Thomas C.; Lui, Philip C.W.; Lo, Anthony W.I.; Scolyer, Richard A.; Law, Bonita K.B.; Karim, Rooshdiya; Lee, C. Soon // Modern Pathology;Jul2004, Vol. 17 Issue 7, p827 

    Mammary phyllodes tumors are uncommon stromal neoplasms, and are divided into benign, borderline and malignant groups basing on histologic criteria. While benign phyllodes tumors may recur, borderline phyllodes tumors show higher propensity to recur locally and rarely metastasize, and malignant...

  • Gadd45a levels in human breast cancer are hormone receptor dependent. Tront, Jennifer S.; Willis, Alliric; Huang, Yajue; Hoffman, Barbara; Liebermann, Dan A. // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: Gadd45a is a member of the Gadd45 family of genes that are known stress sensors. Gadd45a has been shown to serve as an effector in oncogenic stress in breast carcinogenesis in murine models. The present study was aimed at clarifying the expression of Gadd45a in human breast cancer...

  • Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients. He, L.-R.; Zhao, H.-Y.; Li, B.-K.; Zhang, L.-J.; Liu, M.-Z.; Kung, H.-F.; Guan, X.-Y.; Bian, X.-W.; Zeng, Y.-X.; Xie, D. // Annals of Oncology;Aug2010, Vol. 21 Issue 8, p1675 

    Background: The amplified in breast cancer 1 (AIB1) gene has been considered to play an oncogenic role in human cancers, but its clinical/prognostic significance in non-small-cell lung cancer (NSCLC) is still unclear.

  • Mutation status of ras genes in breast cancers with overexpressed p21Ras protein. Yan-Ling Hong; Li-Ying Yang; Xin-Yan Pan; Qiang Feng; Hong Zou; Shu-Ling Song; Li Wang; Peng Wang; Shuang Bai; Xin-Liang Zhou; Ju-Lun Yang // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 10, p10422 

    Ras gene product, p21Ras, was found to be overexpressed in human tumors. However, the subtypes of overexpressed p21Ras and mutation status are still unknown which limits the development of therapeutic antibodies targeting p21Ras. This study aims to investigate the mutation status of ras genes in...

  • Detection of pAkt protein in imprint cytology of invasive breast cancer: Correlation with HER2/neu, hormone receptors, and other clinicopathological variables. Vasou, Olympia; Skagias, Lazaros; Anastasia, Margariti; Paulina, Athanasiadou; Patsouris, Efstratios; Politi, Ekaterini // CytoJournal;2015, Vol. 12 Issue 1, p1 

    Purpose: Akt is a serine/threonine protein kinase and has emerged as a crucial regulator of widely divergent cellular processes, including apoptosis, proliferation, differentiation, and metabolism. Activation of Akt/protein kinase B has been positively associated with human epidermal...

  • HER-2 / neu and Topoisomerase IIa - Simultaneous Drug Targets in Cancer. Tero AH Jarvinen; Edison T Liu // Combinatorial Chemistry & High Throughput Screening;Aug2003, Vol. 6 Issue 5, p455 

    In solid tumors the predominant genetic mechanism for oncogene activation is through amplification of genes. The HER-2 (also known as ErbB2 / c-erbB2 / HER-2 / neu) oncogene is the most frequently amplified oncogene in breast cancer and is also commonly amplified in other forms of cancer....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics